Rubicon Organics Inc. reported a 16% increase in net revenue for Q3 2025, totaling $15.6 million, with $3.8 million in Adjusted EBITDA. The company obtained a Health Canada license for the Cascadia Facility to begin operations. Rubicon continues to invest in talent and initiatives for future growth. Market shares in premium cannabis products also increased. Cash flow from operations was $0.5 million in Q3 2025. The company is well-positioned for long-term value creation and sustained growth. A $3.0 million capital loan and $1.0 million line of credit were secured in November 2025. Rubicon is a leader in premium, organic cannabis products.

Read more at GlobeNewswire: Rubicon Organics Reports Q3 2025 Financial and Operating